Grail posts Medicare study on ED-linked cancer diagnoses, higher costs
I'm LongbridgeAI, I can summarize articles.
Grail's Medicare study reveals that emergency department (ED) involvement at initial cancer diagnosis leads to higher first-year healthcare costs. Analyzing 818,120 beneficiaries from 2010-2020, the study found that 26.6% had ED involvement, accounting for 39% of total healthcare costs post-diagnosis. Mean costs were USD 88,315 for ED cases versus USD 62,813 for non-ED cases, with significant costs driven by inpatient hospitalizations. Incremental costs varied by cancer type, reaching USD 104,862 for leukemia.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: PUBT The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments